Park-Ohio Holdings Corp. (PKOH) At $39.25 Forms Top; Continental Advisors Raised Its Valeant Pharmaceuticals Intl (VRX) Stake

Park-Ohio Holdings Corp. (PKOH) formed multiple top with $40.43 target or 3.00% above today’s $39.25 share price. Park-Ohio Holdings Corp. (PKOH) has $491.83 million valuation. The stock decreased 1.26% or $0.5 during the last trading session, reaching $39.25. About 20,122 shares traded. Park-Ohio Holdings Corp. (NASDAQ:PKOH) has risen 35.53% since March 4, 2017 and is uptrending. It has outperformed by 18.83% the S&P500.

Continental Advisors Llc increased Valeant Pharmaceuticals Intl (VRX) stake by 111.7% reported in 2017Q3 SEC filing. Continental Advisors Llc acquired 104,100 shares as Valeant Pharmaceuticals Intl (VRX)’s stock declined 15.71%. The Continental Advisors Llc holds 197,300 shares with $2.83 million value, up from 93,200 last quarter. Valeant Pharmaceuticals Intl now has $5.18B valuation. The stock decreased 2.49% or $0.38 during the last trading session, reaching $14.88. About 21.28 million shares traded or 26.69% up from the average. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since March 4, 2017 and is downtrending. It has underperformed by 65.21% the S&P500.

Analysts await Park-Ohio Holdings Corp. (NASDAQ:PKOH) to report earnings on March, 6. They expect $0.81 earnings per share, up 22.73% or $0.15 from last year’s $0.66 per share. PKOH’s profit will be $10.15M for 12.11 P/E if the $0.81 EPS becomes a reality. After $0.82 actual earnings per share reported by Park-Ohio Holdings Corp. for the previous quarter, Wall Street now forecasts -1.22% negative EPS growth.

Since September 8, 2017, it had 0 buys, and 4 sales for $1.19 million activity. Another trade for 1,471 shares valued at $67,298 was sold by VILSACK ROBERT D. $623,941 worth of Park-Ohio Holdings Corp. (NASDAQ:PKOH) shares were sold by CRAWFORD MATTHEW V.

Among 4 analysts covering Park-Ohio Holdings Corp. (NASDAQ:PKOH), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. Park-Ohio Holdings Corp. had 4 analyst reports since September 22, 2015 according to SRatingsIntel. The rating was initiated by Sidoti on Tuesday, August 30 with “Buy”. KeyBanc Capital Markets maintained the shares of PKOH in report on Friday, September 15 with “Buy” rating. The firm has “Sell” rating by Zacks given on Tuesday, September 22.

Investors sentiment increased to 1.26 in Q3 2017. Its up 0.14, from 1.12 in 2017Q2. It improved, as 9 investors sold Park-Ohio Holdings Corp. shares while 30 reduced holdings. 15 funds opened positions while 34 raised stakes. 6.94 million shares or 1.41% more from 6.84 million shares in 2017Q2 were reported. 1,147 were reported by Zurcher Kantonalbank (Zurich Cantonalbank). California State Teachers Retirement, a California-based fund reported 14,168 shares. Foundry Ptnrs Ltd Com owns 0.14% invested in Park-Ohio Holdings Corp. (NASDAQ:PKOH) for 79,243 shares. North Star Inv Mgmt stated it has 190 shares. Rice Hall James Associate Limited Liability Corporation reported 56,772 shares. Manatuck Hill Prns Limited Liability owns 17,200 shares. Deprince Race And Zollo Inc stated it has 0.18% of its portfolio in Park-Ohio Holdings Corp. (NASDAQ:PKOH). New Amsterdam Partners Ltd Liability Corp invested in 68,437 shares or 0.65% of the stock. New York-based Renaissance Techs Ltd Limited Liability Company has invested 0% in Park-Ohio Holdings Corp. (NASDAQ:PKOH). Kennedy Capital Incorporated holds 0.06% or 76,515 shares in its portfolio. Ny State Common Retirement Fund invested in 9,100 shares or 0% of the stock. Axa invested in 6,300 shares. Teton Advsrs holds 0.73% of its portfolio in Park-Ohio Holdings Corp. (NASDAQ:PKOH) for 171,900 shares. Legal And General Public Ltd Company has invested 0% in Park-Ohio Holdings Corp. (NASDAQ:PKOH). Olstein Cap Mgmt Lp owns 27,428 shares or 0.16% of their US portfolio.

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.09, from 1.08 in 2017Q2. It dropped, as 43 investors sold VRX shares while 68 reduced holdings. 27 funds opened positions while 83 raised stakes. 169.87 million shares or 1.18% less from 171.89 million shares in 2017Q2 were reported. Janney Montgomery Scott Ltd Company holds 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 20,095 shares. Cubist Systematic Strategies Limited Liability Corp has 0.05% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Gotham Asset Mngmt Ltd Liability Corp holds 475,002 shares or 0.1% of its portfolio. 92,128 are owned by Shell Asset. Nationwide Fund Advsrs accumulated 65,480 shares. Pnc Svcs holds 0% or 8,506 shares in its portfolio. 187,803 were accumulated by Aperio Group Ltd Liability Corporation. Gulf Intl Bancorp (Uk), a United Kingdom-based fund reported 98,923 shares. The Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Fifth Third Bank & Trust holds 546 shares. Evercore Wealth Mngmt Ltd holds 0% or 300 shares in its portfolio. Thompson Davis reported 0.01% stake. Raymond James Ser Advsrs stated it has 0.01% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Moreover, Legal & General Gp Public Ltd Company has 0.02% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 1.58 million shares. Greatmark Inv Partners has 0.14% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX).